Do you want to read an article? Please log in or register.
Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic review
Genitourinary Cancer
Related content
Gastrointestinal Cancer
Induction treatment with FOLFIRINOX or oxaliplatin-based doublet followed by long-course chemoradiotherapy and surgery in locally advanced rectal cancer. A systematic review and pooled analysis from phase II and III trials
Cancer Treat Rev
Moretto R, Vetere G, Carullo M, Ciracì P, Masi G, Cremolini C
doi: 10.1016/j.ctrv.2024.102829
Further Publications
Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis
Cancer Treat Rev
Kistemaker KRJ, Sijani F, Brinkman DJ, de Graeff A, Burchell GL, Steegers MAH, van Zuylen L
doi: 10.1016/j.ctrv.2024.102704
Genitourinary Cancer
Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysis
Prostate Cancer Prostatic Dis
Creta M, Shariat SF, Marra G, Gontero P, Rossanese M, Morra S, Teoh J, Kishan AU, Karnes RJ, Longo N
doi: 10.1038/s41391-024-00883-3
Gynecologic Cancer
Fertility-preserving Treatment for Stage IA Endometrial Cancer: A Systematic Review and Meta-Analysis
Am J Obstet Gynecol
Suzuki Y, Ferris JS, Chen L, Dioun S, Usseglio J, Matsuo K, Xu X, Hershman DL, Wright JD
doi: 10.1016/j.ajog.2024.07.018
Further Publications
Treatment of Stages I-III Squamous Cell Anal Cancer: A Comparative Effectiveness Systematic Review
J Natl Cancer Inst
Troester A, Parikh R, Southwell B, Ester E, Sultan S, Greeno E, Arsoniadis E, Church TR, Wilt T, Butler M, Goffredo P
doi: 10.1093/jnci/djae195
Genitourinary Cancer
Real-word outcomes for high-risk non-muscle-invasive bladder cancer: screened patients for the BRAVO trial
BJU Int
Conroy S, Jubber I, Noon AP, Rosario DJ, Griffin J, Morgan S, Hubbard R, Kennish S, Mitchell S, Venugopal S, Linton K, Rajasundaram R, Hussain SA, Catto JWF
doi: 10.1111/bju.16516
COMMENTED
Genitourinary Cancer
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
BJU Int
Scilipoti P, Longoni M, de Angelis M, Zaurito P, Massiet A, Dutto D, Soria F, Álvarez-Maestro M, Bazán AA, Pradere B, Klatte T, Contieri R, Hurle R, Krajewski W, Subiela JD, Pichler R, Szostek A, Marcq G, Elena JLR, Aranda J, Gontero P, Rouprêt M, Shariat SF, Necchi A, Montorsi F, Briganti A, Xylinas E, Moschini M, EuroGemDoce Study Group Collaborators, European Association of Urology ‐ Young Academic Urologists (EAU‐YAU), Urothelial Carcinoma Working Group
doi: 10.1111/bju.16645
Gynecologic Cancer
Compliance Rate With Triage Test and Treatment for Participants Screening Positive in Cervical Cancer Screening Programs: A Systematic Review and Meta-analysis
Obstet Gynecol
Wang M, Maimaitiming M, Bi Y, Jin Y
doi: 10.1097/AOG.0000000000005723
Lung, Respiratory and Thoracic Cancer
Prevalence of invasive lung cancer in pure ground glass nodules less than 30 mm: A systematic review
Eur J Cancer
AlShammari A, Patel A, Boyle M, Proli C, Gallesio JA, Wali A, De Sousa P, Lim E
doi: 10.1016/j.ejca.2024.115116